Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-05-11 @ 3:22 PM
Study NCT ID:
NCT04762160
Status:
TERMINATED
Last Update Posted:
2024-03-25
First Post:
2021-02-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma
Sponsor:
Epizyme, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Follicular Lymphoma | View |